John C. Stavridis
About
In The Last Decade
John C. Stavridis
22 papers receiving 360 citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 107
- Pharmacology 51
- Health, Toxicology and Mutagenesis 40
- Physiology 40
- Plant Science 36
Countries citing papers authored by John C. Stavridis
This map shows the geographic impact of John C. Stavridis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Stavridis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Stavridis more than expected).
Fields of papers citing papers by John C. Stavridis
This network shows the impact of papers produced by John C. Stavridis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Stavridis. The network helps show where John C. Stavridis may publish in the future.
Co-authorship network of co-authors of John C. Stavridis
This figure shows the co-authorship network connecting the top 25 collaborators of John C. Stavridis. A scholar is included among the top collaborators of John C. Stavridis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Stavridis. John C. Stavridis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | Growth and other factors affecting peak expiratory flow in Greek children. | 3 |
| 3 | 125 | |
| 4 | 7 | |
| 5 | The effect of disease activity related cytokines on the fibrinolytic potential and cICAM-1 expression in rheumatoid arthritis. | 12 |
| 6 | 3 | |
| 7 | 14 | |
| 8 | 21 | |
| 9 | 4 | |
| 10 | 4 | |
| 11 | 26 | |
| 12 | 13 | |
| 13 | 5 | |
| 14 | 14 | |
| 15 | 10 | |
| 16 | The treatment of gynaecological and intra-abdominal infections: a comparative study of cefotetan versus netilmicin plus clindamycin. | 4 |
| 17 | 37 | |
| 18 | 4 | |
| 19 | 1 | |
| 20 | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.